HRT Financial’s AgomAb Therapeutics NV AGMB Stock Holding History
Bought
Maintained
Sold
Other funds holding AGMB
SL
HRT Financial's AGMB Position: Q3 2026 in Review
HRT Financial increased its AgomAb Therapeutics NV (AGMB) stake by 87% in Q3 2026, buying an estimated $192K and bringing the position to 31,881 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #3237.
HRT Financial first reported a position in AGMB in Q1 2026 and has held it in 3 quarters since. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.
- HRT Financial held 31,881 shares of AgomAb Therapeutics NV worth $353K as of Q3 2026.
- HRT Financial bought 14,806 AgomAb Therapeutics NV shares in Q3 2026, an estimated $192K.
- AgomAb Therapeutics NV made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #3237 holding.
- HRT Financial first reported a position in AgomAb Therapeutics NV in Q1 2026 and has held it in 3 quarters since.
- 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.
Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.